Mohammad Taheri
Impact in
- Cancer Research top 0.05%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 0.5%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Extracellular vesicles in disease
- RNA regulation and disease
Papers in
-
- Circular RNAs in diseases 191
- RNA modifications and cancer 118
- RNA Research and Splicing 88
- RNA regulation and disease 44
- Cancer Research 413
- Cancer-related molecular mechanisms research 361
- MicroRNA in disease regulation 187
- Co-authors
- Soudeh Ghafouri‐Fard (251 shared papers)Bashdar Mahmud Hussen (203 shared papers)Hamed Shoorei (71 shared papers)Mir Davood Omrani (122 shared papers)Arezou Sayad (120 shared papers)Atefe Abak (44 shared papers)Rezvan Noroozi (67 shared papers)Shahram Arsang‐Jang (83 shared papers)
In The Last Decade
Mohammad Taheri
683 papers receiving 11.2k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Cancer Research 6.4k
- Molecular Biology 7.4k
- Biological Psychiatry 191
- Immunology 980
- Pathology and Forensic Medicine 637
Countries citing papers authored by Mohammad Taheri
This map shows the geographic impact of Mohammad Taheri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Taheri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Taheri more than expected).
Fields of papers citing papers by Mohammad Taheri
This network shows the impact of papers produced by Mohammad Taheri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Taheri. The network helps show where Mohammad Taheri may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Taheri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 700 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MicroRNA: A signature for cancer progression Hit paper breakdown → | 2021 | 241 |
| 2 | 2019 | 207 | |
| 3 | 2019 | 137 | |
| 4 | 2022 | 123 | |
| 5 | Interplay between PI3K/AKT pathway and heart disorders Hit paper breakdown → | 2022 | 121 |
| 6 | 2021 | 116 | |
| 7 | 2021 | 107 | |
| 8 | 2021 | 98 | |
| 9 | 2020 | 94 | |
| 10 | 2020 | 86 | |
| 11 | 2022 | 86 | |
| 12 | 2022 | 85 | |
| 13 | 2018 | 79 | |
| 14 | 2017 | 77 | |
| 15 | 2020 | 72 | |
| 16 | 2018 | 71 | |
| 17 | 2017 | 70 | |
| 18 | 2021 | 69 | |
| 19 | 2019 | 65 | |
| 20 | 2023 | 64 |
About Mohammad Taheri
Mohammad Taheri is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Epidemiology, having authored 700 papers that have together received 11.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (361 papers), Circular RNAs in diseases (191 papers), MicroRNA in disease regulation (187 papers), RNA modifications and cancer (118 papers), RNA Research and Splicing (88 papers), RNA regulation and disease (44 papers), Cytokine Signaling Pathways and Interactions (42 papers) and Multiple Sclerosis Research Studies (37 papers). The work is most often cited by research in Cancer Research (6.4k citations), Molecular Biology (7.4k citations), Biological Psychiatry (191 citations), Immunology (980 citations) and Pathology and Forensic Medicine (637 citations). Mohammad Taheri has collaborated with scholars based in Iran, Iraq and Germany. Frequent co-authors include Soudeh Ghafouri‐Fard, Bashdar Mahmud Hussen, Hamed Shoorei, Mir Davood Omrani, Arezou Sayad, Atefe Abak, Rezvan Noroozi, Shahram Arsang‐Jang, Mehrdokht Mazdeh and Tayyebeh Khoshbakht. Their work appears in journals such as Journal of Molecular Neuroscience, Biomedicine & Pharmacotherapy, Frontiers in Oncology, Human Antibodies and Experimental and Molecular Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.